OVERVIEW: Johnson & Johnson focuses its healthcare grantmaking on communicable diseases, noncommunicable diseases and mental health.
IP TAKE: This funder often focuses its grantmaking efforts on the most pressing global health, humanitarian and global development challenges.
PROFILE: The Johnson & Johnson Family of Companies Foundation is the philanthropic arm of Johnson & Johnson, a multinational corporation that consists of around 250 operating companies around the world. The foundation aims to “[s]upport the people on the front lines at the heard of delivering care, so that communities and health systems have the ability to address the health needs of thd world’s most vulnerable people.”
Johnson & Johnson’s philanthropy consists of cash grants, in-kind donations and pharmaceutical subsidies. Areas of funding interest include strengthening the healthcare workforce, empowering healthcare advocates and leaders, maternal and newborn health and using technology to transform healthcare delivery systems. The foundation is also dedicated to achieving the 2030 Sustainable Development Goals (SDGs).
Johnson & Johnson continues to address some of the most prolific disease related challenges such as those posed by HIV/AIDS and tuberculosis. The foundation is also addressing the “[i]ncreasing shift in burden of disease toward noncommunicable diseases (NCDs) and mental health. The foundation is particularly interested in “[t]he development of new drug regimens, support[ing] the strengthening of healthcare systems and break[ing] down the barriers to access in resource-limited settings.”
The majority of Johnson & Johnson’s grants range from $25,000 to $100,000. The foundation does not accept unsolicited grant applications or requests for funding.
Search for staff contact info and bios in PeopleFinder (paid subscribers only.)